# Ascensia Diabetes Care signs MOU to transfer Eversense CGM distribution to Senseonics

Ascensia Diabetes Care signed a memorandum of understanding to transfer commercial operations for Eversense Continuous Glucose Monitoring systems to Senseonics Holdings. The transfer is targeted for January 1, 2026, subject to a definitive agreement.

- Type: Contract
- Announced: 2025-09-03
- Status: announced
- Products: Eversense Continuous Glucose Monitoring systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ascensia Diabetes Care](https://endata.com/companies/49233.md)
- [PHC Group](https://endata.com/companies/2478.md) (investor)
- [Senseonics Holdings, Inc.](https://endata.com/companies/49232.md) (partner)

## Sources

- [markets.financialcontent.com](https://markets.financialcontent.com/wral/article/bizwire-2025-9-3-ascensia-diabetes-care-signs-mou-to-transfer-eversense-cgm-distribution-to-strategic-partner-senseonics), 2025-09-03: "Unifying development, manufacturing, and distribution within Senseonics would enable Eversense to accelerate growth and realize its full potential faster than under the current structure."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.